Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Acute rhinitis drug

A technology for acute rhinitis and drugs, applied in the field of western medicine, can solve the problems of mixed effects, high toxic and side effects, and prone to complications, and achieve the effects of relieving pain and economic burden, less toxic and side effects, and improving nasal congestion

Inactive Publication Date: 2017-05-31
HENAN SHUIJINGTOU CULTURAL MEDIA CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A variety of Chinese medicines and Western medicines for acute rhinitis have appeared on the market, and the effects are also mixed. Although some have certain effects, the price is relatively high, and some have serious side effects, which endanger the patient's health; Complicated, poor taste, difficult for patients to adhere to
Western medicine has attracted widespread attention due to its low price, convenient taking, good taste, and easy adherence. More and more patients choose to take western medicine for acute rhinitis, but there are still many problems in the existing western medicine: large toxic and side effects, prone to complications, And easy to relapse, can not fundamentally solve the suffering of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] A medicine for acute rhinitis, comprising the following raw materials in parts by weight: 10-20 parts of phenytoin sodium, 5-10 parts of levocetirizine hydrochloride tablets, 0.1-1 parts of vitamin B6, 5-10 parts of amantadine hydrochloride granules 5-15 parts of sulfamethoxazole, 0.1-1 part of dihydroartemisinin, 10-20 parts of zinc gluconate oral liquid, 0.01-1 part of vitamin E, 0.1-1 part of vitamin C, 2 parts of calcium pantothenate -10 parts, 20-40 parts of olive oil, 1-5 parts of phenylglycine, 2-8 parts of phytantriol, 1-5 parts of glutathione, 1-5 parts of L-histidine, 30- 50 servings.

[0021] A preparation method of medicine for acute rhinitis, comprising the following steps:

[0022] (1) Weigh each raw material according to the above formula and set aside; (2) Mix levocetirizine hydrochloride tablets, sulfamethoxazole, vitamin B6, amantadine hydrochloride granules and calcium pantothenate, grind and sieve 200-300 mesh, dry at 90-105°C for 30-50min; (3) Dih...

Embodiment 2

[0024] A medicine for acute rhinitis, comprising the following raw materials in parts by weight: 10-20 parts of phenytoin sodium, 5-10 parts of levocetirizine hydrochloride tablets, 0.1-1 parts of vitamin B6, 5-10 parts of amantadine hydrochloride granules 5-15 parts of sulfamethoxazole, 0.1-1 part of dihydroartemisinin, 10-20 parts of zinc gluconate oral liquid, 0.01-1 part of vitamin E, 0.1-1 part of vitamin C, 2 parts of calcium pantothenate -10 parts, 20-40 parts of olive oil, 1-5 parts of phenylglycine, 2-8 parts of phytantriol, 1-5 parts of glutathione, 1-5 parts of L-histidine, 30- 50 servings.

[0025] A preparation method of medicine for acute rhinitis, comprising the following steps:

[0026] (1) Weigh each raw material according to the above formula and set aside; (2) Mix levocetirizine hydrochloride tablets, sulfamethoxazole, vitamin B6, amantadine hydrochloride granules and calcium pantothenate, grind and sieve 200-300 mesh, dry at 90-105°C for 30-50min; (3) Dih...

Embodiment 3

[0028] A medicine for acute rhinitis, comprising the following raw materials in parts by weight: 15 parts of phenytoin sodium, 7 parts of levocetirizine hydrochloride tablets, 0.8 parts of vitamin B, 8 parts of amantadine hydrochloride granules, and sulfamethoxazole 12 parts, 0.5 parts of dihydroartemisinin, 12 parts of zinc gluconate oral solution, 0.08 parts of vitamin E, 0.5 parts of vitamin C, 5 parts of calcium pantothenate, 30 parts of olive oil, 3 parts of phenylglycine, 3 parts of phytantriol , 1.2 parts of glutathione, 1.3 parts of L-histidine, 40 parts of ethanol solution.

[0029] A preparation method of medicine for acute rhinitis, comprising the following steps:

[0030](1) Weigh each raw material according to the above formula and set aside; (2) Mix levocetirizine hydrochloride tablets, sulfamethoxazole, vitamin B6, amantadine hydrochloride granules and calcium pantothenate, grind and sieve 220 mesh, dry at 95°C for 35 minutes; (3) Mix dihydroartemisinin, phenyt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an acute rhinitis drug which comprises, by weight, 10-20 parts of dilantin, 5-10 parts of levocetirizine hydrochoride tablets, 0.1-1 part of vitamin B6, 5-10 parts of amantadine hydrochloride granules, 5-15 parts of sulfamethoxazole, 0.1-1 part of dihydroartemisinin, 10-20 parts of zinc gluconate oral liquid, 0.01-1 part of vitamin E, 0.1-1 part of vitamin C, 2-10 parts of calcium pantothenate, 20-40 parts of olive oil, 1-5 parts of phenylglycine, 2-8 parts of phytantriol, 1-5 parts of glutathione, 1-5 parts of L-histidine and 30-50 parts of ethanol solution. The acute rhinitis drug has synergistic effects by raw material compounding, has asthma relieving and diuresis inducing function, can effectively improve allergic rhinitis, can treat both principal and secondary aspects of diseases, is less in toxic and side effects, avoids complications and relieves the pain and the economic burden of patients.

Description

technical field [0001] The invention relates to the field of western medicine, in particular to a medicine for acute rhinitis. Background technique [0002] Allergic rhinitis (allergic rhinitis), also known as allergic rhinitis, is the release of mediators (mainly histamine) mediated by IgE after exposure to allergens in atopic individuals, and a variety of immune active cells and cytokines, etc. The participating chronic inflammatory response diseases of the nasal mucosa are characterized by nasal itching, sneezing, hypersecretion, and swelling of the nasal mucosa. Clinically, the disease is often divided into perennial allergic rhinitis and seasonal allergic rhinitis, the latter also known as "hay fever". Although allergic rhinitis is not a serious disease, it can affect patients' daily life, study and work efficiency, and cause a heavy economic burden. It can induce bronchial asthma, sinusitis, nasal polyps, otitis media, etc. Conjunctivitis occurs simultaneously. [0...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/06A61P11/02A61P37/08A61K36/32A61K33/30A61K31/355A61K31/375A61K31/4166A61K31/4415A61K31/13A61K31/366A61K31/495A61K31/198A61K31/4172A61K31/635A61K31/197A61K31/047
CPCA61K38/06A61K31/047A61K31/13A61K31/197A61K31/198A61K31/355A61K31/366A61K31/375A61K31/4166A61K31/4172A61K31/4415A61K31/495A61K31/635A61K33/30A61K36/32
Inventor 不公告发明人
Owner HENAN SHUIJINGTOU CULTURAL MEDIA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products